跳至主要内容
临床试验/NCT02282488
NCT02282488已完成不适用

Effect of the Level of Dietary Protein on the Infant Hormonal Profile and Body Composition

Société des Produits Nestlé (SPN)2 个研究点 分布在 1 个国家目标入组 238 人开始时间: 2006年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
238
试验地点
2
主要终点
Analysis of IGF-1 value

研究概览

简要总结

A double blind, controlled, randomized, single site clinical trial of 2 parallel groups (Low protein formula =LoF and High protein formula =HiF) with a breastfeeding group (BF) as reference from birth to 1 year of age and a follow up period from 1 year to 5 years of age.

详细描述

The primary objective of this clinical trial is to show that infants taking (from birth) either a formula with a low protein content (LoF) or breast milk will have an IGF-1 level, at 4 months, 25% lower to the IGF-1 measured in infants that received a high protein content formula (HiF).

The secondary objectives are: The hormonal profile; the Fat mass (FM) gain and the Lean mass (LM); the metabolomics and aminogramm during the first year of life.

Subjects are included in the study for a duration of 5 years. From birth to 4 months they are exclusively fed BF or FF. From 4 months of age they can start diversification, but they maintain the starter formulas until 12 months (the BF group will receive LoF). Subjects are then followed up until 5 years of age.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Day 至 7 Days(Child)
性别
All
接受健康志愿者

入选标准

  • . Healthy newborn infant
  • Full term infant (= 37 weeks gestation; = 42 weeks gestation)
  • Birth weight = 2500 g and < 4200 g
  • Singleton birth
  • Infant is = 7 days of age at the time of enrollment
  • For the BF group: The infant's mother has elected to exclusively breastfeed her baby, from enrollment to 4 months of age For the FF groups: The infant's mother has elected to exclusively formula feed her baby, from enrollment to 4 months of age
  • Having obtained his/her or his/her legal representative's consent

排除标准

  • Newborn whose mother's BMI was normal (<20 or = 25) at start of pregnancy
  • Newborn whose mother had developed gestational diabetes during pregnancy
  • Newborn whose mother has diabetes of type-1 or type-2
  • Newborn whose mother smoked > 5 cigarettes / day during pregnancy
  • Newborn whose mother had a drug dependence during pregnancy
  • Newborn whose mother has a chronic infectious disease
  • Newborn whose parents / caregivers cannot be expected to comply with treatment
  • Newborn currently participating in another clinical trial

研究组 & 干预措施

Group Breastfeeding

No Intervention

Breastfeeding

Group 1: Low protein formula

Experimental

Low protein formula

干预措施: Low protein formula (Other)

Group 2: high protein formula

Experimental

High protein formula

干预措施: High protein formula (Other)

结局指标

主要结局

Analysis of IGF-1 value

时间窗: 4 months

Analyse the IGF-1 value and compare it

次要结局

  • DEXA scan as a measure of the body composition(2 weeks, 4 months and 12 months)
  • Hormonal profile analysis (Insulin, C-peptide, Glucose, octanoyl ghrelin, Leptin and IGF-1)(2 weeks, 4 months and 12 months)
  • aminogramm analysis(2 weeks, 4 months and 12 months)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验